Abstract
Clinical diagnostics is an attractive and growing industry, with the majority
of major diagnostic companies experiencing sales growth of over 10% in2008,
despite significant pricing pressures. However, achieving market growth is
becoming increasingly challenging due to the difficulty in developing novel
diagnostics for new high value markets, or which can add appreciable clinical
benefit in existing markets. ' Innovations in In-Vitro Diagnostics' is a new
report published by Business Insights that provides an in-depth analysis of
emerging opportunities and potential clinical advances across the diagnostics
markets of coronary heart disease, heart failure, bacterial infections and
viral infections. This report explores the major trends and issues that are
shaping the development of novel diagnostics and assesses the future prospects
of leading innovations. The market segments with the greatest growth
opportunities are identified and the competitive landscape of the market is
also assessed, with profiles of nine major diagnostics companies, based on
market presence, R&D focus, acquisitions, historical sales and number of
immunoanalyzers.
| 
View Cart
